Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Figure 2

Randomized controlled trials of bisphosphonates in improving spinal BMD in IBD. Forest plot showing the weighted mean differences and 95% confidence interval of the percentage change in BMD in the lumbar spine in the bisphosphonate and control groups. A subgroup analysis of the treatment duration of the two groups is also shown.